The global nuclear medicine market is expanding rapidly, thanks to advances in diagnostic imaging and targeted treatments.

近日，复旦大学附属肿瘤医院核医学科宋少莉教授团队的最新研究成果「Pilot study of Nectin-4–targeted PET imaging agent 68Ga-FZ-NR-1 in triple-negative breast cancer from bench to first in human」作为封面文章和特色文章发表在核医学领域权威期刊《Journal of Nuclear ...

The FDA-approved imaging agent for detecting coronary artery disease gained Medicare and Medicaid coverage starting April 1.

By Elizabeth Piper LONDON (Reuters) -In the nuclear medicine department of London's University College Hospital, patients ...

This longstanding course is designed to teach the scientific principles upon which nuclear medicine imaging is based. It gives an introduction to the underlying physics and radiochemistry principles ...

The global nuclear imaging equipment market is experiencing robust growth, projected to increase from USD 2.7 billion in 2021 to approximately USD 3.9 billion by 2028, with a steady CAGR of 5.2%. This ...

All patients needing urgent diagnostic scans were seen on time ... Image caption, Dr Randeep Kulshrestha runs the Nuclear Medicine department at the Bristol Royal Infirmary At the Bristol Royal ...

A new bachelors degree is helping address a critical workforce shortage in Queensland with hands-on clinical training ...

Priya Jacob has contributed to nuclear medicine and radiation oncology by integrating AI-driven diagnostics, optimizing PET-CT and SPECT-CT, and enhancing treatment precision. Her work in Theranostics ...

The Asia-Pacific nuclear medicine market was valued at $4,116.43 million in 2020, and is projected to reach $8,957.89 million by 2028, registering a CAGR of 10.4% from 2021 to 2028. The market is ...